Accessibility Menu
Escalon Medical logo

Escalon Medical

(OTC) ESMC

Current Price$0.19
Market Cap$1.41M
Since IPO (1992)-100%
5 Year-41%
1 Year+9%
1 Month-2%

Escalon Medical Financials at a Glance

Market Cap

$1.41M

Revenue (TTM)

$2.68B

Net Income (TTM)

$239.86M

EPS (TTM)

$-0.04

P/E Ratio

-5.04

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$0.19

Volume

6,000

Open

$0.21

Previous Close

$0.19

Daily Range

$0.19 - $0.21

52-Week Range

$0.10 - $0.46

ESMC News

No articles available.

ESMC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Escalon Medical

Industry

Healthcare Equipment and Supplies

Employees

39

CEO

Richard J. DePiano, Jr.

Headquarters

Wayne, PA 19087, US

ESMC Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

-8%

Net Income Margin

-9%

Return on Equity

-13%

Return on Capital

-85%

Return on Assets

-48%

Earnings Yield

-19.84%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.41M

Shares Outstanding

7.42M

Volume

6.00K

Short Interest

0.00%

Avg. Volume

5.57K

Financials (TTM)

Gross Profit

$5.51M

Operating Income

$133.22K

EBITDA

$166.04K

Operating Cash Flow

$380.73M

Capital Expenditure

$0.00

Free Cash Flow

$380.73M

Cash & ST Invst.

$545.84M

Total Debt

$523.30K

Escalon Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.59M

+11.5%

Gross Profit

$1.56M

-1.1%

Gross Margin

43.33%

N/A

Market Cap

$1.41M

N/A

Market Cap/Employee

$35.22K

N/A

Employees

40

N/A

Net Income

$97.68K

-60.3%

EBITDA

$107.16K

-58.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$336.61M

+75042.9%

Accounts Receivable

$2.24M

+38.9%

Inventory

$1.52B

+88595.4%

Long Term Debt

$604.41K

+140.0%

Short Term Debt

$215.67K

+179.1%

Return on Assets

-48.17%

N/A

Return on Invested Capital

-85.28%

N/A

Free Cash Flow

$517.41M

-172032.4%

Operating Cash Flow

$517.41M

-172032.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BINPBionoid Pharma, Inc.
$0.03-0.00%
MJNAMedical Marijuana, Inc.
$0.00-0.00%
EVFMEvofem Biosciences, Inc.
$0.01-5.56%
DTRKDATATRAK International, Inc.
$0.37-7.50%

Trending Stocks

Symbol / CompanyPricePrice Chg
ANNAAleAnna
$6.92+0.83%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.51-0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.67+0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.37-0.05%

Questions About ESMC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.